Diagnostic performances of D-dimer, prothrombin time, and red blood cell distribution width for coronary artery lesion in children with acute stage Kawasaki disease
暂无分享,去创建一个
[1] Wenhui Jiang,et al. Red cell distribution in critically ill patients with chronic obstructive pulmonary disease. , 2022, Pulmonology.
[2] K. Dou,et al. Association of circulating proprotein convertase subtilisin/kexin type 9 concentration, prothrombin time and cardiovascular outcomes: a prospective cohort study , 2021, Thrombosis Journal.
[3] H. Cao,et al. Red Blood Cell Distribution Width as a Predictive Marker for Coronary Artery Lesions in Patients with Kawasaki Disease , 2021, Pediatric Cardiology.
[4] A. Biswas,et al. The Relationship between Inflammatory Cytokines and Coagulopathy in Patients with COVID-19 , 2021, Journal of clinical medicine.
[5] T. Kuijpers,et al. CT Angiography or Cardiac MRI for Detection of Coronary Artery Aneurysms in Kawasaki Disease , 2021, Frontiers in Pediatrics.
[6] W. Koenig,et al. Inflammation and Cardiovascular Disease: The Future , 2021, European cardiology.
[7] T. Tilak,et al. Relation of D-dimer levels of COVID-19 patients with diabetes mellitus , 2020, Diabetes & Metabolic Syndrome: Clinical Research & Reviews.
[8] A. Gedalia,et al. Kawasaki Disease: an Update , 2020, Current Rheumatology Reports.
[9] [Recommendations for clinical management of Kawasaki disease with coronary artery lesions (2020 revision)]. , 2020, Zhonghua er ke za zhi = Chinese journal of pediatrics.
[10] Jie Tian,et al. Insights Into Coronary Artery Lesions in Kawasaki Disease , 2020, Frontiers in Pediatrics.
[11] D. Burgner,et al. Kawasaki disease fact check: Myths, misconceptions and mysteries , 2020, Journal of paediatrics and child health.
[12] Yonghong Guo,et al. Predictive value of heart rate deceleration capacity on coronary artery lesion in acute phase of Kawasaki disease , 2020, Scientific Reports.
[13] Y. Hua,et al. N-terminal pro-brain natriuretic peptide as a biomarker for predicting coronary artery lesion of Kawasaki disease , 2020, Scientific Reports.
[14] S. Berkowitz,et al. Enhancing the Quality of Rivaroxaban Exposure Estimates Using Prothrombin Time in the Absence of Pharmacokinetic Sampling , 2019, CPT: pharmacometrics & systems pharmacology.
[15] P. Langford,et al. Kawasaki Disease: The Role of Immune Complexes Revisited , 2019, Front. Immunol..
[16] N. Lu,et al. Serum D-dimer levels at admission for prediction of outcomes in acute pancreatitis , 2019, BMC Gastroenterology.
[17] P. Fang,et al. Correlations of complication with coronary arterial lesion with VEGF, PLT, D-dimer and inflammatory factor in child patients with Kawasaki disease. , 2018, European review for medical and pharmacological sciences.
[18] Ping Huang,et al. Is aspirin necessary in the acute phase of Kawasaki disease? , 2018, Journal of paediatrics and child health.
[19] G. Kim,et al. Factors Predicting Resistance to Intravenous Immunoglobulin Treatment and Coronary Artery Lesion in Patients with Kawasaki Disease: Analysis of the Korean Nationwide Multicenter Survey from 2012 to 2014 , 2017, Korean circulation journal.
[20] M. Singhal,et al. Role of imaging studies in Kawasaki disease , 2017, International journal of rheumatic diseases.
[21] B. McCrindle,et al. Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association , 2017, Circulation.
[22] D. Agrawal,et al. Kawasaki disease: etiopathogenesis and novel treatment strategies , 2017, Expert review of clinical immunology.
[23] J. Lim,et al. Age-adjusted plasma N-terminal pro-brain natriuretic peptide level in Kawasaki disease , 2016, Korean journal of pediatrics.
[24] G. Dangas,et al. The current role and future prospects of D-dimer biomarker. , 2016, European heart journal. Cardiovascular pharmacotherapy.
[25] D. Masuya,et al. Increased Red Blood Cell Distribution Width Associates with Cancer Stage and Prognosis in Patients with Lung Cancer , 2013, PloS one.
[26] K. Patel,et al. Comparative analysis of red cell distribution width and high sensitivity C-reactive protein for coronary heart disease mortality prediction in multi-ethnic population: findings from the 1999-2004 NHANES. , 2013, International journal of cardiology.
[27] T. Richards,et al. Expansion of the red cell distribution width and evolving iron deficiency as predictors of poor outcome in chronic heart failure. , 2013, International journal of cardiology.
[28] T. Shimo,et al. Prediction of the Risk of Coronary Arterial Lesions in Kawasaki Disease by Brain Natriuretic Peptide , 2011, Pediatric Cardiology.
[29] L. Ferrucci,et al. Serum antioxidants and inflammation predict red cell distribution width in older women: the Women's Health and Aging Study I. , 2010, Clinical nutrition.
[30] Kuender D Yang,et al. Plasma Clusterin Levels in Predicting the Occurrence of Coronary Artery Lesions in Patients With Kawasaki Disease , 2010, Pediatric Cardiology.
[31] Ş. Balta,et al. Red cell distribution width: a novel inflammatory marker in clinical practice. , 2013, Cardiology journal.
[32] M. Yılmaz,et al. Usefulness of admission red cell distribution width as a predictor of early mortality in patients with acute pulmonary embolism. , 2012, The American journal of cardiology.
[33] V. Preedy,et al. Prospective Cohort Study , 2010 .
[34] L. Ferrucci,et al. The Women’s Health and Aging Study , 2001 .
[35] K. Johnson. An Update. , 1984, Journal of food protection.
[36] J. Cattell. The Future of , 1961 .